IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson's disease models.
Arcos J, Grunenwald F, Sepulveda D, Jerez C, Urbina V, Huerta T, Troncoso-Escudero P, Tirado D, Perez A, Diaz-Espinoza R, Nova E, Kubitscheck U, Rodriguez-Gatica JE, Hetz C, Toledo J, Ahumada P, Rojas-Rivera D, Martín-Montañez E, Garcia-Fernandez M, Vidal RL.
Arcos J, et al. Among authors: martin montanez e.
Cell Death Discov. 2023 Dec 2;9(1):438. doi: 10.1038/s41420-023-01734-1.
Cell Death Discov. 2023.
PMID: 38042807
Free PMC article.